(LLY) Eli Lilly - Performance 12.6% in 12m
Compare LLY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
72.36%
#6 in Group
Rel. Strength
73.86%
#2088 in Universe
Total Return 12m
12.58%
#43 in Group
Total Return 5y
443.73%
#4 in Group
P/E 71.9
94th Percentile in Group
P/E Forward 36.8
77th Percentile in Group
PEG 1.22
60th Percentile in Group
FCF Yield 0.16%
43th Percentile in Group
12m Total Return: LLY (12.6%) vs XLV (-3.4%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
7.23% | 182% | 396% | 50.6 | 37.7 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
-2.33% | 12.6% | 444% | 71.9 | 36.8 | 1.22 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.42% | 20.4% | 62.4% | 18.9 | 13.6 | 1.29 | 36.2% | 11.6% |
SFZN SW Siegfried Holding |
-1.55% | 0.98% | 99% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-5.79% | 1.95% | 60.7% | 24 | 20.2 | 1.47 | -20.8% | -17% |
NOVN SW Novartis |
-8.67% | 7.45% | 35% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
SAN PA Sanofi |
-14.3% | 7.15% | 23.5% | 20.7 | 10.9 | 0.88 | -22.1% | -24.8% |
SOBI ST Swedish Orphan Biovitrum |
-9.44% | 0.08% | 38.7% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
Performance Comparison: LLY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for LLY
Total Return (including Dividends) | LLY | XLV | S&P 500 |
---|---|---|---|
1 Month | -2.33% | -9.22% | -8.88% |
3 Months | 10.38% | -6.61% | -14.53% |
12 Months | 12.58% | -3.42% | 4.14% |
5 Years | 443.73% | 44.91% | 98.04% |
Trend Score (consistency of price movement) | LLY | XLV | S&P 500 |
1 Month | -57.8% | -82.9% | -74.2% |
3 Months | -27.4% | -44.4% | -89.4% |
12 Months | -11.6% | -3.9% | 64% |
5 Years | 98.1% | 90% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #39 | 7.59% | 7.19% |
3 Month | #20 | 18.2% | 29.2% |
12 Month | #41 | 16.6% | 8.10% |
5 Years | #4 | 275% | 175% |
FAQs
Does LLY Eli Lilly outperforms the market?
Yes,
over the last 12 months LLY made 12.58%, while its related Sector, the Health Care Sector SPDR (XLV) made -3.42%.
Over the last 3 months LLY made 10.38%, while XLV made -6.61%.
Over the last 3 months LLY made 10.38%, while XLV made -6.61%.
Performance Comparison LLY vs Indeces and Sectors
LLY vs. Indices LLY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 13.1% | 6.55% | 1.97% | 8.44% |
US NASDAQ 100 | QQQ | 13.8% | 7.46% | 2.89% | 8.54% |
US Dow Jones Industrial 30 | DIA | 14.3% | 6.68% | 1.01% | 11.2% |
German DAX 40 | DAX | 7.32% | 5.02% | -18.2% | -5.41% |
Shanghai Shenzhen CSI 300 | CSI 300 | 7.97% | 1.23% | -3.87% | 4.77% |
Hongkong Hang Seng | HSI | 8.32% | 5.85% | -2.82% | -1.36% |
India NIFTY 50 | INDA | 4.58% | -5.30% | -4.44% | 9.70% |
Brasil Bovespa | EWZ | 7.68% | 2.83% | -3.01% | 24.8% |
LLY vs. Sectors LLY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 12.5% | 7.05% | -7.0% | 0.52% |
Consumer Discretionary | XLY | 13.6% | 6.03% | -1.0% | 5.81% |
Consumer Staples | XLP | 9.21% | -5.09% | -10.1% | 1.87% |
Energy | XLE | 8.19% | 11.2% | 1.03% | 26.8% |
Financial | XLF | 11.6% | 5.04% | -6.82% | -0.86% |
Health Care | XLV | 12.8% | 6.89% | 2.24% | 16.0% |
Industrial | XLI | 12.0% | 4.77% | 1.60% | 10.2% |
Materials | XLB | 10.8% | 4.54% | 7.68% | 21.6% |
Real Estate | XLRE | 8.87% | 1.64% | -1.37% | -0.74% |
Technology | XLK | 14.6% | 9.71% | 9.32% | 15.2% |
Utilities | XLU | 10.7% | 0.57% | -3.87% | -5.93% |
Aerospace & Defense | XAR | 11.4% | 0.82% | -6.88% | -7.97% |
Biotech | XBI | 9.79% | 11.0% | 13.6% | 22.3% |
Homebuilder | XHB | 11.7% | 6.21% | 17.2% | 23.9% |
Retail | XRT | 10.1% | 2.37% | 4.63% | 19.3% |